The phase I study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancer.

Trial Profile

The phase I study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 May 2016

At a glance

  • Drugs Docetaxel (Primary) ; Fluorouracil (Primary) ; Nedaplatin (Primary)
  • Indications Oesophageal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top